
The U.S. District Court for the Western District of Texas dismissed a lawsuit filed by Canadian cannabis giant Canopy Growth (NASDAQ:CGC) against GW Pharmaceuticals on Feb. 25th. The lawsuit was initially filed in 2020, and since then, Britain’s GW Pharma was acquired by the biopharmaceutical company Jazz Pharmaceuticals (NASDAQ:JAZZ).
In the lawsuit, Canopy accused GW Pharma of unauthorized usage of Canopy’s intellectual property related to a CBD extraction method.